Navigation Links
Surfaxin (Lucinactant) Long-Term Survival Advantage vs. Comparators,Published in Pediatrics

er in Europe and current market growth driver in United States.

* Although treatment with Surfaxin improved survival in preterm children, no differences in neurologic outcomes through one-year of life were observed between treatment groups, however, Surfaxin demonstrated a statistically significant (p less than or equal to 0.05) reduction in two important assessments of neurologic outcomes (reflex abnormality and gross tone) versus Survanta.

Robert J. Capetola, President and CEO of Discovery Labs, commented, "Publication of these data in Pediatrics represents an important validation of Surfaxin, the cornerstone of Discovery's broad SRT pipeline. The neonatal medical community has repeatedly indicated a strong interest in long-term outcomes assessment. No such assessment from the registration trials supporting use of currently prescribed animal-derived products has, to our knowledge, ever been conducted. Discovery is committed to provide this critically important information to the neonatal community. The article by Dr. Moya et al. supports a defined survival advantage for Surfaxin compared with current standard of care. We believe these long-term data will support significant differentiation for Surfaxin."

About Surfaxin

Surfaxin is a precision-engineered version of natural human lung surfactant and contains Discovery Labs' KL-4 peptide. Surfaxin, administered as a liquid-instillate, represents a potential alternative to the commercially available animal-derived surfactants. Data from Discovery Labs pivotal, multinational SELECT study demonstrate that Surfaxin is significantly more effective in the prevention of RDS and results in improved survival (continuing through at least one year of life) and other outcomes versus comparator surfactants. The SELECT and STAR (a supportive Phase 3 study) trials, as well as the pooled Phase 3 analysis, have been presented at several international medical meetings and the results from the two studies we
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Discovery Labs Presents Surfaxin and Aerosurf Data At the Pediatric Academic Societies Annual Meeting
2. Anesiva Announces Phase 2 Data Showing Substantial, Long-Term Pain Reductions with Adlea(TM) (formerly 4975) in Osteoarthritis of the Knee
3. Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III Melanoma Demonstrated Significant and Sustained Impact on Relapse-Free Survival
4. Long-Term Extension of Ulcerative Colitis Study Shows Remicade Responders Maintained Improvement Through Two Years of Follow-Up
5. New Long-Term Data Analyses for Bifeprunox Show Favorable Effects Versus Placebo in Stabilized Patients with Schizophrenia
6. Medtronic Updates Long-Term ENDEAVOR I-II Clinical Data Showing Sustained Safety and Significant Reductions in Repeat Procedures
7. Taxus VI Clinical Trial Demonstrates Positive Long-Term Outcomes for Moderate-Release Paclitaxel-Eluting Stent at Four Years
8. UCB Presents Long-Term CImzia Data in Crohns Disease
9. PDL BioPharma Announces Long-Term Nuvion Data Presented at 2007 Digestive Disease Week
10. New Study Results Provide Additional Data about Short- and Long-Term Use of Desvenlafaxine Succinate in the Treatment of Adults with Major Depressive Disorder
11. Gilead Announces Presentation of Long-Term Data for Ambrisentan, a Potential Treatment for Patients With Pulmonary Arterial Hypertension
Post Your Comments:
(Date:2/27/2015)... 2015  Two mass spectrometry technologies MALDI ... their effectiveness is established, according to biotechnology ... says that while mass spectrometry (mass spec ... in proteomic biomarker discovery and validation, mass ... techniques has struggled to elucidate molecular distribution ...
(Date:2/26/2015)... -- Today the National Safety Council released a ... effects of pain medications , debunking ... Oxycontin, are safer options than over-the-counter pain relievers. ... on heroin and cocaine combined," said Deborah A.P. ... medications are marketed as the Cadillac option for treating ...
(Date:2/26/2015)... 2015 Every year many millions of donations ... disease.  Nevertheless, year after year doctors and the medical ... first test to determine the status of heart health ... not, even though that technology is over 100 years ... doctors know, (while most patients do not know) that ...
Breaking Medicine Technology:Report: "Softer" Mass Spec Techniques Gaining Popularity in Biomarker Discovery 2Report: "Softer" Mass Spec Techniques Gaining Popularity in Biomarker Discovery 3National Safety Council: Opioid prescription painkillers have hidden, deadly side effects 2National Heart Health Month In February 2
(Date:2/28/2015)... 2015 March—also known as National ... remind ourselves and others that suspected head injuries, ... Specialists (ANS). , Concussions are a form of ... of TBIs. There are 1.6-3.8 million sports-related concussions ... but it is a brain injury. Many athletes ...
(Date:2/28/2015)... CA (PRWEB) February 28, 2015 A ... a promising new gene therapy procedure for the treatment ... blindness in patients. Authored by Dr. Robert ... and published in the Lancet Medical Journal on January ... from choroideremia, a rare genetic disorder that mostly affects ...
(Date:2/28/2015)... 28, 2015 National Sales ... sales, marketing and supply chain management for consumer ... is bringing its award winning solutions for thinning-damaged ... products are specifically created to combat thinning-damaged hair. ... is committed to marrying science with nature to ...
(Date:2/28/2015)... Kaylie Corrigan, Outdoor Supervisor at Back2Basics Outdoor ... student obtaining her Masters degree in social work at ... psychoeducation on substance use for teens at the local ... her studies. , “Even though these students are young, ... the high school and junior high school level,” said ...
(Date:2/28/2015)... The noted Toronto plastic surgeon Dr. David Ellis ... in the January/February 2015 issue of Elevate magazine. On ... featured in an article entitled “Get the Look: Kim ... Cattrall has possibly undergone to maintain her youthful appearance ... horizontal lines or frown line creases, which can be ...
Breaking Medicine News(10 mins):Health News:Atlantic NeuroSurgical Specialists (ANS) Focus on National Brain Injury Awareness Month to Educate the General Public on Head Trauma 2Health News:Atlantic NeuroSurgical Specialists (ANS) Focus on National Brain Injury Awareness Month to Educate the General Public on Head Trauma 3Health News:New Gene Therapy Procedure Could Hold Key to Preventing Blindness for Certain Patients 2Health News:BIOTA Botanicals Brings Thinning-Damaged Hair Solutions to the Hair Care Aisle at Walgreens 2Health News:BIOTA Botanicals Brings Thinning-Damaged Hair Solutions to the Hair Care Aisle at Walgreens 3Health News:Staff at Arizona Drug Addiction Treatment Center Starts Teen Sobriety Support Group at Local High School 2Health News:Dr. David Ellis Featured In Elevate Magazine 2
... and computed tomography (CT) scanning of patients in ... physicians to determine whether the cancer has spread ... surgery, according to researchers at the SNM,s 55th ... be reduced, which would also lower morbidity rates ...
... 2008) Rapid information processing in the ... between nerve cells and their targets. One ... transmitter acetylcholine to communicate between nerve cells. ... and memory, arousal, attention, and all autonomic ...
... NEW YORK, June 16 WebMD Health Corp. (Nasdaq:,WBMD) ... that executives,of WebMD are scheduled to participate at the ... 18, 2008 at 1:30 p.m. ET., Investors, analysts ... a,live audio broadcast of the presentation over the Internet. ...
... Jersey Hospital, RIDGEWOOD, N.J., June 16 Ridgewood resident,David ... historic charitable contribution to The Valley Hospital in,Ridgewood, NJ. The ... its main campus, is thought to be the largest single ... gift to Valley because I want my giving to do ...
... Will Grade Each State and the Nation;,Initiative Will Engage ... March of Dimes,has extended its Prematurity Campaign by 10 ... globally. The expansion, announced at the Surgeon,General,s Conference on ... created during the two-day conference here to address the,growing ...
... finds that hospitals that perform well on the Leapfrog ... than those who,either didn,t perform as well on the ... study was published in the June 2008 issue of ... "This study is cause for celebration. Leapfrog works. Organizations ...
Cached Medicine News:Health News:PET/CT scan could be valuable noninvasive tool for determining stages of ovarian cancer 2Health News:The APCs of nerve cell function 2Health News:WebMD to Present at the William Blair 28th Annual Growth Stock Conference 2Health News:The Valley Hospital in Ridgewood, NJ, Announces Historic $30 Million Gift 2Health News:March of Dimes Announces Prematurity Campaign Expansion at Surgeon General's Conference on Preterm Birth 2Health News:March of Dimes Announces Prematurity Campaign Expansion at Surgeon General's Conference on Preterm Birth 3Health News:Harvard Study in Joint Commission Journal: Mortality Rates Lower in Leapfrog Hospitals 2Health News:Harvard Study in Joint Commission Journal: Mortality Rates Lower in Leapfrog Hospitals 3
... Per-fit™ flexible PVC tube with a tapered ... designed to reduce insertion force and more ... kit s unique obturator/dilator design is engineered ... an easier transition through the tissue into ...
... and cost control. , ,Our full ... variety of wound dressing components for the ... patient. , ,Tray configurations include full ... inner cannula for both rigid and flexible ...
... convenience and cost control. , ,Our ... a variety of wound dressing components for ... tracheostomized patient. , ,Tray configurations include ... disposable inner cannula for both rigid and ...
... cost control. , ,Our full range ... of wound dressing components for the effective ... , ,Tray configurations include full trays, ... cannula for both rigid and flexible D.I.C.® ...
Medicine Products: